Halozyme Therapeutics Inc. Common Stock vs Patterson-UTI Energy Inc. Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $112.53 (market cap $12.58B), while Patterson-UTI Energy Inc. Common Stock trades at $11.42 (market cap $4.38B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 2.9× Patterson-UTI Energy Inc. Common Stock's market cap, and Patterson-UTI Energy Inc. Common Stock pays a 3.48% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Patterson-UTI Energy Inc. Common Stock for 0 Days on average.
| HALO | PTEN | |
|---|---|---|
Market Cap | $12.58B | $4.38B |
Volume | 2,179,278 | 5,834,535 |
Sector | Health | Energy |
52-Week High | $115.22 | $13.15 |
52-Week Low | $61.63 | $5.37 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $14.49B | $5.46B |
Dividend Yield | — | 3.48% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →Patterson-UTI Energy provides drilling, completion, and other oilfield services for oil and gas producers in the United States.
Read more on PTEN →